ICON Stock

ICON FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of ICON (ICLR) as of Aug 10, 2026 is 375.86 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 141.33 % — a change of 165.94% (higher).

FCF Conversion

375.86 %

YoY

165.94%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of ICON is 2026 375.86 % . FCF Conversion Rate (FCF/EBITDA) of ICON was 2025 141.33 % . It decreases by 165.94% higher compared to the previous year.
Access this data via the Eulerpool API

ICON Stock analysis

What does ICON do? ICON PLC is a global company specializing in clinical research and development of pharmaceuticals. The company was founded in 1990 and is headquartered in Dublin, Ireland. It was formed through the merger of several smaller companies. Today, ICON PLC is one of the world's leading companies in the field of clinical trials. ICON is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICON stock

FCF Conversion Rate (FCF/EBITDA) of ICON is 375.86 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of ICON changed from 141.33 % to 375.86 %, representing a 165.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) ICON since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s ICON with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — ICON

All Key Metrics — ICON